ES
Evan Seigerman BMO Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
6.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
62.5%
Neutral
37.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $372 |
10%
upside
| 1 | +10% |
0
%
| 3 Dec ‘25 5 hours ago |
|
|
|
Market Perform
Maintained
| $46 |
3%
downside
| 2 | -26% |
0
%
| 25 Nov ‘25 8 days ago |
|
|
|
Outperform
Maintained
| $30 |
16%
upside
| 2 | +42% |
0
%
| 18 Nov ‘25 15 days ago |
|
|
|
Outperform
Maintained
| $1,100 |
5%
upside
| 1 | +13% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Market Perform
Upgraded
| $11 |
10%
upside
| 1 | -161% |
0
%
| 3 Nov ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $240 |
7%
upside
| 1 | +11% |
0
%
| 12 Sep ‘25 2 months ago |
|